China Universal Asset Management Company’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.07M | Sell |
27,817
-3,154
| -10% | -$1.03M | 0.85% | 24 |
|
|
2025
Q1 | $8.36M | Sell |
30,971
-8,026
| -21% | -$2.17M | 0.78% | 22 |
|
|
2024
Q4 | $9.18M | Buy |
38,997
+2,657
| +7% | +$625K | 0.86% | 22 |
|
|
2024
Q3 | $9.99M | Buy |
36,340
+9,831
| +37% | +$2.7M | 1.1% | 18 |
|
|
2024
Q2 | $6.44M | Sell |
26,509
-9,313
| -26% | -$2.26M | 0.91% | 31 |
|
|
2024
Q1 | $5.35M | Buy |
35,822
+9,662
| +37% | +$1.44M | 0.68% | 39 |
|
|
2023
Q4 | $5.01M | Buy |
26,160
+22,580
| +631% | +$4.32M | 0.97% | 26 |
|
|
2023
Q3 | $634K | Sell |
3,580
-9,492
| -73% | -$1.68M | 0.18% | 100 |
|
|
2023
Q2 | $2.48M | Buy |
13,072
+9,868
| +308% | +$1.87M | 0.77% | 39 |
|
|
2023
Q1 | $642K | Sell |
3,204
-10,400
| -76% | -$2.08M | 0.22% | 85 |
|
|
2022
Q4 | $3.23M | Buy |
13,604
+12,480
| +1,110% | +$2.97M | 1.3% | 21 |
|
|
2022
Q3 | $225K | Buy |
+1,124
| New | +$225K | 0.09% | 92 |
|